NCT04355507 (STOIC) is a clinical trial of Chest computed tomography (CT) in COVID-19, sponsored by Assistance Publique - Hôpitaux de Paris.

Who is sponsoring NCT04355507?

NCT04355507 is sponsored by Assistance Publique - Hôpitaux de Paris.

What drugs are being tested in NCT04355507?

Interventions in NCT04355507: Chest computed tomography (CT), Reverse-transcription polymerase chain reaction (RT-PCR).

Is NCT04355507 still recruiting?

NCT04355507 is currently completed. Last updated 21 January 2026.

Last reviewed 2026-01-21 · How we verify

NCT04355507: STOIC

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Computed Tomography for COVID-19 Diagnosis

Completed Last updated 21 January 2026

What this trial tests

trial testing Chest computed tomography (CT) in COVID-19 in 10,735 participants. Completed in 16 October 2020.

Timeline

1 March 2020

Primary endpoint
16 October 2020

16 October 2020

Quick facts

Lead sponsor	Assistance Publique - Hôpitaux de Paris
Status	Completed
Study type	OBSERVATIONAL
Enrollment	10,735
Start date	1 March 2020
Primary completion	16 October 2020
Estimated completion	16 October 2020
Sites	1 location across France

Drugs / interventions tested

Chest computed tomography (CT)
Reverse-transcription polymerase chain reaction (RT-PCR)

Conditions studied

COVID-19 — all drugs for COVID-19 →

Sponsor

Assistance Publique - Hôpitaux de Paris — full company profile →

Who can join

18 and older, any sex, with COVID-19. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to build a large dataset of Computed Tomography (CT) images for identification of accurate CT criteria and development of deep learning-based solutions for diagnosis, quantification and prognostic estimation.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Study of Thoracic CT in COVID-19: The STOIC Project.
Revel MP, Boussouar S, de Margerie-Mellon C, Saab I, et al · · 2021 · cited 26× · PMID 34184935 · DOI 10.1148/radiol.2021210384
The STOIC2021 COVID-19 AI challenge: applying reusable training methodologies to private data
Boulogne LH, Lorenz J, Kienzle D, Schon R, et al · · 2023

Verify or expand the search:

Other recruiting trials for COVID-19

Currently open trials in the same condition.

NCT07183709 — Safety and Immunogenicity Trial of PepGNP-COVID19 Vaccine in Adults · Phase 1 · active not recruiting
NCT07300839 — A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age · Phase 3 · active not recruiting
NCT07221162 — A Safety and Immunogenicity Trial of Boost-2867 Vaccine, Via Intranasal and Intramuscular Routes · Phase 1 · recruiting
NCT07215520 — Safety and Tolerability of a Newcastle Disease Virus-Based Mucosal COVID-19 Vaccine in Previously Vaccinated Adults · Phase 2 · recruiting
NCT07222384 — A Study to Learn About BNT162b2 (LP.8.1)-Adapted Vaccine Against SARS-CoV-2 in Children 5 Through 11 Years of Age That A · Phase 3 · active not recruiting

Other Assistance Publique - Hôpitaux de Paris trials

Trials by the same sponsor.

NCT07443436 — Immunomodulatory Treatment of Interstitial Lung Disease Associated With Surfactant Related Gene Variants · Phase 2 · not yet recruiting
NCT07499492 — Red Blood Cell Transfusion to Optimize Extubation · NA · not yet recruiting
NCT07379918 — Real-life Evaluation of Endopredict® in Early HR+/HER2- Breast Cancer · recruiting
NCT07473869 — Smartphone Application for Automated Measurement of Capillary Refill Time (CRT) · not yet recruiting
NCT07505394 — Efficacy of a Prediction Model-based Algorithm to PREVENT Drug-induced Impulse Control Disorders in Parkinson's Disease · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04355507 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assistance Publique - Hôpitaux de Paris
Last refreshed: 21 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04355507.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing